Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) Document date: 2020_3_23
ID: 9hknw4ws_35
Snippet: With respect to other secondary outcomes, the rate of antipyresis, rate of cough resolution, and rate of improvement on chest CT imaging at day 7 and 14 did not show any statistical difference between the three groups (P > 0.05)......
Document: With respect to other secondary outcomes, the rate of antipyresis, rate of cough resolution, and rate of improvement on chest CT imaging at day 7 and 14 did not show any statistical difference between the three groups (P > 0.05).
Search related documents:
Co phrase search for related documents- chest CT imaging and secondary outcome: 1, 2
- chest CT imaging and statistical difference: 1, 2
- chest CT imaging improvement and CT imaging: 1, 2
- CT imaging and secondary outcome: 1, 2, 3, 4, 5, 6
- CT imaging and statistical difference: 1, 2, 3, 4, 5, 6, 7, 8, 9
- secondary outcome and statistical difference: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date